Difficult conference life. #iwcart #southbeach #miamibaby

#iwCART24 | @mshadman (@fredhutch) discusses CD20-targeted auto CAR-T for #FollicularLymphoma #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Nirali Shah discusses CAR-T in pediatric #AML Promising progress in pediatric cancer therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

Nirav Shah presents bispecific CAR20.19 T-cells in #MCL Stay informed about the latest advancements in #lymphoma therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymsm

Caron Jacobson (@DanaFarberNews) introduces CRG-022, CD22 CAR T-cell therapy for R/R #LBCL after CD19 CAR-T #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Gloria Iacoboni (@gloria_iacoboni/@vallhebron) discusses optimizing treatment through BsAbs sequencing Join us for this informative session! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Jay Spiegel (@jayspiegel25/@SylvesterCancer) presents total therapy for #LBCL combining mosun/pola/axi-cel #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Tycel Phillips provides glofitamab RWD and trials in progress Join us for this informative session on bispecific therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

At #iwCART24 @KrishPatelMD explores RWD and trials in progress for epcoritamab Stay informed about the latest advancements in bispecific therapy on VJHemOnc.com @VJHemOnc #iwCART #CART #Lymphoma #Lymsm

Jeremy Abramson (@MassGeneral) presents new data in liso cel for #FollicularLymphoma, MZL, and MCL #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Matteo Doglio presents CAR-Tregs for autoimmunity! Promising advancements in #AutoimmuneDisease therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

Pere Barba (@pebarba/@Hemato_Vhebron) presents YTB323 in severe, refractory systemic lupus erythematosus Stay informed about the latest advancements in autoimmune disease therapy! #iwCART24 @VJHemOnc #iwCART #CART #Lupus

Jeremias Motte discusses anti-CD19 CAR T-cell therapy (KYV-101) in subjects with refractory generalized myasthenia gravis. Exciting progress in autoimmune disease therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

Next at #iwCART24 @R_L_Gardner (@UW) presents SCRI-CAR19 with CD19 T-APC to prolong CAR T-cell persistence. Exciting progress in CAR-T therapy! @VJHemOnc #iwCART #CART #CellularTherapies #ALL #Leusm

#iwCART24 | @drclaireroddie (@uclcancer) provides updates and future directions on Obe-cel. Stay informed about the latest advances in #ALL therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

#iwCART24 | @may_daher (@MDAndersonNews) explores allogeneic CAR-NK cells in adults with #AML or #MDS #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

We have @KrishPatelMD who introduces iPSC-derived CAR-NK. Stay informed about the latest advancements in cellular therapies! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

Next up, @LNastoupilMD (@MDAndersonNews) discusses CRISPR-edited allogeneic anti-CD19 CAR T-cell therapy for R/​R B-cell #NHL #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymphoma #Lymsm

Bijal Shah (@MoffittNews) presents updates for Allo CAR-T PBCAR0191. Exciting progress in allo CAR-T therapy! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies

#iwCART24 | @DrFredLocke (@MoffittNews) provides updates for ALLO-647/501 in r/r large B-cell and #FollicularLymphoma Stay informed about allo approaches! #iwCART24 @VJHemOnc #iwCART #CART #CellularTherapies #Lymsm